Importance Mild strokes have been poorly represented in thrombolytic trials and only a few
series have reported outcomes after treatment with intravenous (IV) recombinant tissue
plasminogen activator (rtPA) after mild stroke. Objective To report treatment complications
and short-term outcomes in patients with mild stroke who have received treatment with IV
rtPA. Design, Setting, and Participants Retrospective analysis of patients treated in the
emergency department of hospitals that use the Get With the Guidelines–Stroke registry, a …